Were These Hedge Funds Wrong About Exelixis, Inc. (EXEL)?
Is Exelixis, Inc. (NASDAQ:EXEL) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by...
Posts Tagged ‘NASDAQ:EXEL’
Hedge Funds Have Never Been This Bullish On Exelixis, Inc. (EXEL)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Did Hedge Funds Make The Right Call On Exelixis, Inc. (EXEL) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Hedge Funds Going Back and Forth About Exelixis, Inc. (EXEL)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Were These Hedge Funds Right About Selling Exelixis, Inc. (EXEL)?
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published an article with the title Recession...
2019 Review: Top Hedge Fund Stocks vs. Exelixis, Inc. (EXEL)
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating...
Hedge Funds Are Warming Up To Exelixis, Inc. (EXEL)
Hedge funds are known to underperform the bull markets but that’s not because they are bad at investing. Truth be told, most hedge fund managers...
Is Exelixis, Inc. (EXEL) Going To Burn These Hedge Funds ?
“Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn’t by much. Cumulatively...
Hedge Fund and Insider Trading News: George Soros, Per Johansson, Neil Woodford, Highfields Capital, Exelixis, Inc. (EXEL), J.Jill Inc (JILL), and More
Faced with Rising Far Right, Soros Foundations Look West (Reuters) BERLIN (Reuters) – George Soros’s Open Society Foundations, best known for...
Here’s What Hedge Funds Think About Exelixis, Inc. (EXEL)
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due...
Did Hedge Funds Drop The Ball On Exelixis, Inc. (EXEL) ?
Does Exelixis, Inc. (NASDAQ:EXEL) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company...
Do Hedge Funds Love Exelixis, Inc. (EXEL)?
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited...
Exelixis, Symantec, Weight Watchers International and More: Here’s Why These Stocks Are Moving
Seeing as how several stocks are on the move due to earnings today, let’s take a look at some of the more notable ones, including that of Exelixis...
Hedge Fund and Insider Trading News: David Tepper, Tricadia Capital Management, Tiger Management, MongoDB Inc. (MDB), Infusystem Holdings Inc (INFU), Cullen/Frost Bankers, Inc. (CFR), and More
Hedge Fund Billionaire David Tepper Reaches Deal to Buy the Carolina Panthers (CNBC) Billionaire hedge fund manager David Tepper has reached a deal to...
Billionaire Fund Managers Are Bullish On These Biotech Stocks
The biotech sector is well known for its M&A activity, but billionaire fund managers don’t seem to be attracted by the frenzy. They seem to prefer...
Financial Markets Snapshot: 35 Fresh Stories Telling How is it Going in the Finance World Today
1. U.S. Stock Market: “U.S. equities traded higher on Friday as concerns about Donald Trump’s presidency recede for the time being. The Dow...
Should You Buy Exelixis, Inc. (EXEL)?
The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines. Of...
The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3
Baker Bros. Advisors has arguably been the most successful healthcare-focused hedge fund on the Street in recent years. Founded by brothers Julian Baker...
This Biotech Hedge Fund’s Stock Picks Killed It in Q3
Hedge funds returned about 4% so far this year and underperformed the S&P 500 Index again. Hedge fund investors have been withdrawing their capital...
Deere & Company (DE), Gas Natural Inc. (EGAS) & More: Why These Stocks are Trending Today
The US stock market is trading higher today, despite some weakness across global indexes. Among individual stocks that are showing more volatility today...
Earnings Wrap: Transocean (RIG), XPO Logistics (XPO), Exelixis (EXEL), 2 More
All three index futures are pointing north in pre-market trading as the Bank of England just announced that it would cut interest rates for the first...
Facebook, CME Group Among 5 Stocks That Recently Hit 52-Week Highs
Seeing as how the S&P 500 and the Dow Jones are near record highs, it’s not surprising that many stocks have recently hit 52-week highs as well...
Here’s Why These Five Stocks Are Surging Today
It’s been a pretty good day on Wall Street so far as the Dow Jones Index is up almost 100 points and all three major indexes are in the green. The...
Pay Attention to These 5 Stocks Making Big Moves Today
The Dow Jones is slightly in the red today as market sentiment dips on a more mixed batch of earnings results being released today. Origin Agritech...
Why Are These Stocks Trading Deep in Red on Friday?
The key technical levels of 18,000 for the Dow and 2,100 for the S&P seem out of reach today as each index is in the red on the back of disappointing...
Why These 5 Stocks Are Making Moves Higher Today
Wall Street has recorded moderate gains on the first day of March, with crude prices being the main catalyst for the stock exchanges. Meanwhile, there...
What Do Hedge Funds Think of Exelixis, Inc. (EXEL)?
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients’ money, and needless to say, they are painstakingly...
Did Hedge Funds Sell Out Of Exelixis, Inc. (EXEL) Too Soon? Shares Jump On Regulatory Approval of Cobimetinib
The shares of Exelixis, Inc. (NASDAQ:EXEL) have jumped by 3.01% in today’s trading session, as the company announced the first regulatory approval...
Exelixis, Inc. (EXEL) Soars Following Cancer Drug Trial Data, But Competition Looms
Shares of Exelixis, Inc. (NASDAQ:EXEL) have soared by more than 50% today following the release of positive phase 3 trial data from a test of its cancer...
An Excellent Investment in the Biotech Space?
According to the American Cancer Society, more than 60,000 new cases of thyroid cancer will be diagnosed in the U.S., and about 1,850 people are expected...
AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?
The small patient pool for medullary thyroid cancer, or MTC, isn’t going to move the needle for a large pharmaceutical company. But Exelixis, Inc...
New York Community Bancorp, Inc. (NYCB), Exelixis, Inc. (EXEL): Here’s What This $53 Billion Hedge Fund Company Has Been Buying
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a...
Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age. Although there are more than...
Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)
What’s a smart Puma Biotechnology Inc (NYSE:PBYI) investor to do? In today’s marketplace, there are dozens of methods market participants can...
Is Achillion Pharmaceuticals, Inc. (ACHN) Going to Burn These Hedge Funds?
Is Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) a good investment? To the average investor, there are dozens of indicators market participants can use...
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In today’s marketplace, there are tons of gauges market participants can use to track their holdings. A duo of the most innovative are hedge fund and...
Exelixis, Inc. (EXEL), Vertex Pharmaceuticals Incorporated (VRTX), Celgene Corporation (CELG): Want Multibaggers? Consider These 3 Biotech Companies
In after hours trading on April 18, a few hours after the release of my previous article focusing on Exelixis, Inc. (NASDAQ:EXEL), Vertex Pharmaceuticals...
Cytokinetics, Inc. (CYTK), Exelixis, Inc. (EXEL): Three Small Cap Biotech Stocks with Great Potential
Small cap stocks are a bit riskier, but offer more growth than the stable large cap ones. The biotech sector in U.S. has a number of small cap stocks...
Here is What Hedge Funds Think About Puma Biotechnology Inc (PBYI)
Is Puma Biotechnology Inc (NYSE:PBYI) a buy here? Hedge funds are betting on the stock. The number of bullish hedge fund bets improved by 2 lately. In...
Is Exelixis, Inc. (EXEL) Going to Burn These Hedge Funds?
Exelixis, Inc. (NASDAQ:EXEL) has experienced a decrease in enthusiasm from smart money in recent months. If you’d ask most investors, hedge funds...
Do Hedge Funds and Insiders Love Celldex Therapeutics, Inc. (CLDX)?
Celldex Therapeutics, Inc. (NASDAQ:CLDX) investors should be aware of an increase in hedge fund interest lately. In the financial world, there are plenty...
Achillion Pharmaceuticals, Inc. (ACHN): Are Hedge Funds Right About This Stock?
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) investors should pay attention to an increase in hedge fund interest in recent months. To most stock holders...
Bristol Myers Squibb Co. (BMY), Ariad Pharmaceuticals, Inc. (ARIA): ASCO Investment Ideas
The American Society of Clinical Oncology annual meeting kicks off today. The scientific conference is the premier place for oncology companies to present...
ImmunoGen, Inc. (IMGN), AEterna Zentaris Inc. (USA) (AEZS) – Tackling Cancer: Your Best Investing Ideas
Over the past three months, we’ve taken a deep dive into the 12 cancer types most likely to be diagnosed in the U.S. this year according to the...
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds and Insiders Are Bearish, What Should You Do?
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) shareholders have witnessed a decrease in hedge fund interest recently. If you’d ask most shareholders,...
Liberty Media Corp (LMCA), Sarepta Therapeutics Inc (SRPT): Here’s What This $42 Billion Hedge Fund Company Has Been Buying
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a...
Chesapeake Energy Corporation (CHK), Discovery Communications Inc. (DISCA): Here’s What This $21 Billion Hedge Fund Company Has Been Buying
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a...
SolarCity Corp (SCTY), Exelixis, Inc. (EXEL): Watch These Stocks
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated. Without my watchlist, I’d be unable to keep up on...
AstraZeneca plc (ADR) (AZN), Exelixis, Inc. (EXEL), Pfizer Inc. (PFE) & Tackling Cancer: Thyroid Cancer’s Biggest Current and Upcoming Players
As I noted eight weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing...
Amazon.com, Inc. (AMZN), And How The Roth IRA Rules!
If you’re going through life assuming that there isn’t much difference between a traditional IRA and a Roth IRA, you’re doing yourself...
